Evidence map›Paper›PMID 36164608›Full record

ArticlePeerJ2022

Association between

Xu Han, Tianyu Liu, Jiabao Zhai, Chang Liu, Wanyu Wang, Chuang Nie, Qi Wang, Xiaojie Zhu, Haibo Zhou, Wenjing Tian

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Association ofTranslational cancer research · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xu HanDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Tianyu LiuDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Jiabao ZhaiDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Chang LiuDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Wanyu WangDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Chuang NieDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Qi WangDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Xiaojie ZhuDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Haibo ZhouDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Wenjing TianDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Altered DNA methylation, genetic alterations, and environmental factors are involved in tumorigenesis. As a tumor suppressor gene, abnormal Methods: A total of 366 GC cases and 374 controls were selected as the subjects of this study to collect their environmental factors, and the Results: After PS adjustment, Conclusions:

Indexed as

Stomach NeoplasmsAgedDNA MethylationHumansLeukocytesPrognosisReceptor, EphA5RiskEPHA5 protein, humanReceptor, EphA5Environmental factorsEPHA5 methylationGastric cancerPeripheral blood leukocytes

Identifiers

PMID36164608
PMCPMC9508887
OpenAlexW4296755251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.